Molecular Diagnosis of Mast Cell Disorders

Slides:



Advertisements
Similar presentations
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Advertisements

Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E
Mastocytosis Molecular
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
Performance Evaluation of the TheraTyper-GJB2 Assay for Detection of GJB2 Gene Mutations  Ji-Yong Chun, Soo-Kyung Shin, Kyung Tae Min, Woojae Cho, Jaeil.
Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-β Binding Protein-1L Promoter  Tomomi Higashi, Satoru Kyo, Masaki.
Volume 125, Issue 3, Pages (September 2003)
Β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia  Joong Won Lee, Qiaofang Chen, Daniel.
Comprehensive Analysis of CBFβ-MYH11 Fusion Transcripts in Acute Myeloid Leukemia by RT-PCR Analysis  ShriHari S. Kadkol, Annette Bruno, Carol Dodge,
Mutation Screening in Juvenile Polyposis Syndrome
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Systemic Mastocytosis Associated with Chronic Idiopathic Myelofibrosis
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Kazunori Kanehira, Douglas L. Riegert-Johnson, Dong Chen, Lawrence E
Demonstration That Mast Cells, T Cells, and B Cells Bearing the Activating Kit Mutation D816V Occur in Clusters within the Marrow of Patients with Mastocytosis 
Jeung-Yeal Ahn, Katie Seo, Olga Weinberg, Scott D. Boyd, Daniel A
Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts  Marina.
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR  Marie.
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Performance Evaluation of the TheraTyper-GJB2 Assay for Detection of GJB2 Gene Mutations  Ji-Yong Chun, Soo-Kyung Shin, Kyung Tae Min, Woojae Cho, Jaeil.
Shaoyu Zhou, Keyaunoosh Kassauei, David J. Cutler, Giulia C
William L. Gerald, M.D., Ph.D, 1954–2008
Low Copy Number DNA Template Can Render Polymerase Chain Reaction Error Prone in a Sequence-Dependent Manner  Mansour Akbari, Marianne Doré Hansen, Jostein.
The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations  Michaël Boudewijns, Jacques.
Catherine E. Keegan, Anthony A. Killeen 
Analysis of Rare APC Variants at the mRNA Level
A Synonymous Mutation in the CFTR Gene Causes Aberrant Splicing in an Italian Patient Affected by a Mild Form of Cystic Fibrosis  Valeria Faa′, Alessandra.
Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay  Kathleen.
The Molecular Pathology of Primary Immunodeficiencies
Iris Schrijver, Tiffanee J. Lenzi, Carol D. Jones, Marla J
Detection and Discrimination between Deletional and Non-Deletional Prader-Willi and Angelman Syndromes by Methylation-Specific PCR and Quantitative Melting.
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia 
Molecular Monitoring of Chronic Myelogenous Leukemia
A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations  Bárbara Angulo, Elena García-García, Rebeca.
Mast cell activation syndrome: Proposed diagnostic criteria
Characterization of Aberrant Melting Peaks in Unlabeled Probe Assays
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
N. Scott Reading, Stephen D. Jenson, Jeffrey K. Smith, Megan S
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
A Novel Method for Creating Artificial Mutant Samples for Performance Evaluation and Quality Control in Clinical Molecular Genetics  Michael Jarvis, Ramaswamy.
Homozygous Transthyretin Mutation in an African American Male
Identification of Activating c-kit Mutations in Adult-, but not in Childhood-Onset Indolent Mastocytosis: A Possible Explanation for Divergent Clinical.
The Detection of t(14;18) in Archival Lymph Nodes
Standard Mutation Nomenclature in Molecular Diagnostics
Detection of the Activating JAK2 V617F Mutation in Paraffin-Embedded Trephine Bone Marrow Biopsies of Patients with Chronic Myeloproliferative Diseases 
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Rebecca L. Margraf, Rong Mao, Carl T. Wittwer 
An Allele-Specific RT-PCR Assay to Detect Type A Mutation of the Nucleophosmin-1 Gene in Acute Myeloid Leukemia  Tiziana Ottone, Emanuele Ammatuna, Serena.
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene  Marie-Pierre.
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Danielle C. Smith, Alina Esterhuizen, Jacquie Greenberg 
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
A Real-Time PCR Assay for the Simultaneous Detection of Functional N284I and L412F Polymorphisms in the Human Toll-Like Receptor 3 Gene  Robert A. Brown,
Olivier Rosmorduc, Raoul Poupon  Gastroenterology 
A New Insertion/Deletion of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Accounts for 3.4% of Cystic Fibrosis Mutations in Sardinia: Implications.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
Karen Snow-Bailey, Ph.D., 1961–2006
Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations  Athanasios C. Tsiatis, Alexis Norris-Kirby,
Hirokatsu Yanagihori, Noritaka Oyama, Koichiro Nakamura, Fumio Kaneko 
KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors  Christopher L. Corless, Laura McGreevey, Ajia Town, Arin Schroeder, Troy Bainbridge,
Xiangfeng Cui, Helen Feiner, Honghua Li 
A Mutation in the V1 Domain of K16 is Responsible for Unilateral Palmoplantar Verrucous Nevus  Alessandro Terrinoni, Vincenzo De Laurenzi, Eleonora Candi,
Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature  Can N. Kocabas, MD, Akif.
Maureen J. O'Sullivan, Peter A. Humphrey, Louis P. Dehner, John D
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Detection of the Single Hotspot Mutation in the JH2 Pseudokinase Domain of Janus Kinase 2 in Bone Marrow Trephine Biopsies Derived from Chronic Myeloproliferative.
Lung Adenocarcinoma Harboring Mutations in the ERBB2 Kinase Domain
Presentation transcript:

Molecular Diagnosis of Mast Cell Disorders Cem Akin  The Journal of Molecular Diagnostics  Volume 8, Issue 4, Pages 412-419 (September 2006) DOI: 10.2353/jmoldx.2006.060022 Copyright © 2006 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 Multifocal clusters of mast cells in a bone marrow biopsy visualized by immunohistochemical staining for tryptase satisfy the World Health Organization major diagnostic criterion in this patient with indolent systemic mastocytosis. The Journal of Molecular Diagnostics 2006 8, 412-419DOI: (10.2353/jmoldx.2006.060022) Copyright © 2006 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 2 Mast cells in bone marrow aspirate smears show aberrant morphological features such as spindling and hypogranulation (A), as compared to normal mast cells with a round and centrally located nucleus and dense cytoplasmic granulation (B). The Journal of Molecular Diagnostics 2006 8, 412-419DOI: (10.2353/jmoldx.2006.060022) Copyright © 2006 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 3 C-kitmutations in mastocytosis. EC, extracellular (ligand binding); TM, transmembrane; JM, juxtamembrane; TK, tyrosine kinase domain. The most common mutation, D816V, is shown boxed. The Journal of Molecular Diagnostics 2006 8, 412-419DOI: (10.2353/jmoldx.2006.060022) Copyright © 2006 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 4 Demonstration of D816V c-kitmutation by RFLP (A) and capillary sequencing (B). A:HinfI digestion of the RT-PCR product from HMC1.2 cell line (lane 1, positive control) and patient samples in lanes 4 and 6 show the presence of an additional band (arrow) as a result of creating a new restriction site by A>T nucleotide change in c-kitcodon 816. Lanes 2, 3, and 5 show wild-type pattern codon 816. B: Demonstration of the heterozygous A>T nucleotide change in cDNA position 2468 (corresponding to amino acid change D816V) by direct capillary sequencing (right), and its comparison to the wild-type sequence (left). The Journal of Molecular Diagnostics 2006 8, 412-419DOI: (10.2353/jmoldx.2006.060022) Copyright © 2006 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions